Selected research
Industry Research
Serum-free Medium for Cells Industry Research Report 2026
Market perspective
The global Serum-free Medium for Cells market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Serum-free Medium for Cells is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Serum-free Medium for Cells is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Serum-free Medium for Cells is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Serum-free Medium for Cells include BioLifeSolutions, Biological Industries, Corning Inc, Cytiva, FUJIFILM Irvine Scientific, GE Healthcare, HiMedia Laboratories, Nippon Genetics and PromoCell, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Serum-free Medium for Cells market in terms of revenue (US$ million) and, where applicable, sales volume (ml), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/ml) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Serum-free Medium for Cells Market by Company
BioLifeSolutions
Biological Industries
Corning Inc
Cytiva
FUJIFILM Irvine Scientific
GE Healthcare
HiMedia Laboratories
Nippon Genetics
PromoCell
R&D Systems (Bio-Techne)
Rohto Pharmaceutical
Beijing Cellapy Biological
Beijing T&L Biotechnology
Beijing Sino Biological
Beijing Yocon Biology
Cytocraft
Thermo Fisher Scientific
Serum-free Medium for Cells Segment by Type
With DMSO
Without DMSO
Serum-free Medium for Cells Segment by Application
Research Centers
Biopharma Industry
Clinical Research Organizations
Others
Serum-free Medium for Cells Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Serum-free Medium for Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Serum-free Medium for Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Serum-free Medium for Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Serum-free Medium for Cells manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Serum-free Medium for Cells by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Serum-free Medium for Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- With DMSO
- Without DMSO
Applications
- Research Centers
- Biopharma Industry
- Clinical Research Organizations
- Others
Companies covered
- BioLifeSolutions
- Biological Industries
- Corning Inc
- Cytiva
- FUJIFILM Irvine Scientific
- GE Healthcare
- HiMedia Laboratories
- Nippon Genetics
- PromoCell
- R&D Systems (Bio-Techne)
- Rohto Pharmaceutical
- Beijing Cellapy Biological
- Beijing T&L Biotechnology
- Beijing Sino Biological
- Beijing Yocon Biology
- Cytocraft
- Thermo Fisher Scientific
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Serum-free Medium for Cells Market Size (2021-2032)
- 2.2.2 Global Serum-free Medium for Cells Sales (2021-2032)
- 2.2.3 Global Serum-free Medium for Cells Market Average Price (2021-2032)
- 2.3 Serum-free Medium for Cells by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 With DMSO
- 2.3.3 Without DMSO
- 2.4 Serum-free Medium for Cells by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Research Centers
- 2.4.3 Biopharma Industry
- 2.4.4 Clinical Research Organizations
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Serum-free Medium for Cells Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Serum-free Medium for Cells Sales (ml) of Manufacturers (2021-2026)
- 3.3 Global Serum-free Medium for Cells Revenue of Manufacturers (2021-2026)
- 3.4 Global Serum-free Medium for Cells Average Price by Manufacturers (2021-2026)
- 3.5 Global Serum-free Medium for Cells Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Serum-free Medium for Cells, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Serum-free Medium for Cells, Product Type & Application
- 3.8 Global Manufacturers of Serum-free Medium for Cells, Established Date
- 3.9 Global Serum-free Medium for Cells Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 BioLifeSolutions
- 4.1.1 BioLifeSolutions Company Information
- 4.1.2 BioLifeSolutions Business Overview
- 4.1.3 BioLifeSolutions Serum-free Medium for Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 BioLifeSolutions Serum-free Medium for Cells Product Portfolio
- 4.1.5 BioLifeSolutions Recent Developments
- 4.2 Biological Industries
- 4.2.1 Biological Industries Company Information
- 4.2.2 Biological Industries Business Overview
- 4.2.3 Biological Industries Serum-free Medium for Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Biological Industries Serum-free Medium for Cells Product Portfolio
- 4.2.5 Biological Industries Recent Developments
- 4.3 Corning Inc
- 4.3.1 Corning Inc Company Information
- 4.3.2 Corning Inc Business Overview
- 4.3.3 Corning Inc Serum-free Medium for Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Corning Inc Serum-free Medium for Cells Product Portfolio
- 4.3.5 Corning Inc Recent Developments
- 4.4 Cytiva
- 4.4.1 Cytiva Company Information
- 4.4.2 Cytiva Business Overview
- 4.4.3 Cytiva Serum-free Medium for Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Cytiva Serum-free Medium for Cells Product Portfolio
- 4.4.5 Cytiva Recent Developments
- 4.5 FUJIFILM Irvine Scientific
- 4.5.1 FUJIFILM Irvine Scientific Company Information
- 4.5.2 FUJIFILM Irvine Scientific Business Overview
- 4.5.3 FUJIFILM Irvine Scientific Serum-free Medium for Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 FUJIFILM Irvine Scientific Serum-free Medium for Cells Product Portfolio
- 4.5.5 FUJIFILM Irvine Scientific Recent Developments
- 4.6 GE Healthcare
- 4.6.1 GE Healthcare Company Information
- 4.6.2 GE Healthcare Business Overview
- 4.6.3 GE Healthcare Serum-free Medium for Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 GE Healthcare Serum-free Medium for Cells Product Portfolio
- 4.6.5 GE Healthcare Recent Developments
- 4.7 HiMedia Laboratories
- 4.7.1 HiMedia Laboratories Company Information
- 4.7.2 HiMedia Laboratories Business Overview
- 4.7.3 HiMedia Laboratories Serum-free Medium for Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 HiMedia Laboratories Serum-free Medium for Cells Product Portfolio
- 4.7.5 HiMedia Laboratories Recent Developments
- 4.8 Nippon Genetics
- 4.8.1 Nippon Genetics Company Information
- 4.8.2 Nippon Genetics Business Overview
- 4.8.3 Nippon Genetics Serum-free Medium for Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Nippon Genetics Serum-free Medium for Cells Product Portfolio
- 4.8.5 Nippon Genetics Recent Developments
- 4.9 PromoCell
- 4.9.1 PromoCell Company Information
- 4.9.2 PromoCell Business Overview
- 4.9.3 PromoCell Serum-free Medium for Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 PromoCell Serum-free Medium for Cells Product Portfolio
- 4.9.5 PromoCell Recent Developments
- 4.10 R&D Systems (Bio-Techne)
- 4.10.1 R&D Systems (Bio-Techne) Company Information
- 4.10.2 R&D Systems (Bio-Techne) Business Overview
- 4.10.3 R&D Systems (Bio-Techne) Serum-free Medium for Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 R&D Systems (Bio-Techne) Serum-free Medium for Cells Product Portfolio
- 4.10.5 R&D Systems (Bio-Techne) Recent Developments
- 4.11 Rohto Pharmaceutical
- 4.11.1 Rohto Pharmaceutical Company Information
- 4.11.2 Rohto Pharmaceutical Business Overview
- 4.11.3 Rohto Pharmaceutical Serum-free Medium for Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Rohto Pharmaceutical Serum-free Medium for Cells Product Portfolio
- 4.11.5 Rohto Pharmaceutical Recent Developments
- 4.12 Beijing Cellapy Biological
- 4.12.1 Beijing Cellapy Biological Company Information
- 4.12.2 Beijing Cellapy Biological Business Overview
- 4.12.3 Beijing Cellapy Biological Serum-free Medium for Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Beijing Cellapy Biological Serum-free Medium for Cells Product Portfolio
- 4.12.5 Beijing Cellapy Biological Recent Developments
- 4.13 Beijing T&L Biotechnology
- 4.13.1 Beijing T&L Biotechnology Company Information
- 4.13.2 Beijing T&L Biotechnology Business Overview
- 4.13.3 Beijing T&L Biotechnology Serum-free Medium for Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Beijing T&L Biotechnology Serum-free Medium for Cells Product Portfolio
- 4.13.5 Beijing T&L Biotechnology Recent Developments
- 4.14 Beijing Sino Biological
- 4.14.1 Beijing Sino Biological Company Information
- 4.14.2 Beijing Sino Biological Business Overview
- 4.14.3 Beijing Sino Biological Serum-free Medium for Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Beijing Sino Biological Serum-free Medium for Cells Product Portfolio
- 4.14.5 Beijing Sino Biological Recent Developments
- 4.15 Beijing Yocon Biology
- 4.15.1 Beijing Yocon Biology Company Information
- 4.15.2 Beijing Yocon Biology Business Overview
- 4.15.3 Beijing Yocon Biology Serum-free Medium for Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Beijing Yocon Biology Serum-free Medium for Cells Product Portfolio
- 4.15.5 Beijing Yocon Biology Recent Developments
- 4.16 Cytocraft
- 4.16.1 Cytocraft Company Information
- 4.16.2 Cytocraft Business Overview
- 4.16.3 Cytocraft Serum-free Medium for Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Cytocraft Serum-free Medium for Cells Product Portfolio
- 4.16.5 Cytocraft Recent Developments
- 4.17 Thermo Fisher Scientific
- 4.17.1 Thermo Fisher Scientific Company Information
- 4.17.2 Thermo Fisher Scientific Business Overview
- 4.17.3 Thermo Fisher Scientific Serum-free Medium for Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Thermo Fisher Scientific Serum-free Medium for Cells Product Portfolio
- 4.17.5 Thermo Fisher Scientific Recent Developments
5 Global Serum-free Medium for Cells Market Scenario by Region
- 5.1 Global Serum-free Medium for Cells Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Serum-free Medium for Cells Sales by Region: 2021-2032
- 5.2.1 Global Serum-free Medium for Cells Sales by Region: 2021-2026
- 5.2.2 Global Serum-free Medium for Cells Sales by Region: 2027-2032
- 5.3 Global Serum-free Medium for Cells Revenue by Region: 2021-2032
- 5.3.1 Global Serum-free Medium for Cells Revenue by Region: 2021-2026
- 5.3.2 Global Serum-free Medium for Cells Revenue by Region: 2027-2032
- 5.4 North America Serum-free Medium for Cells Market Facts & Figures by Country
- 5.4.1 North America Serum-free Medium for Cells Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Serum-free Medium for Cells Sales by Country (2021-2032)
- 5.4.3 North America Serum-free Medium for Cells Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Serum-free Medium for Cells Market Facts & Figures by Country
- 5.5.1 Europe Serum-free Medium for Cells Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Serum-free Medium for Cells Sales by Country (2021-2032)
- 5.5.3 Europe Serum-free Medium for Cells Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Serum-free Medium for Cells Market Facts & Figures by Country
- 5.6.1 Asia Pacific Serum-free Medium for Cells Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Serum-free Medium for Cells Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Serum-free Medium for Cells Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Serum-free Medium for Cells Market Facts & Figures by Country
- 5.7.1 South America Serum-free Medium for Cells Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Serum-free Medium for Cells Sales by Country (2021-2032)
- 5.7.3 South America Serum-free Medium for Cells Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Serum-free Medium for Cells Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Serum-free Medium for Cells Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Serum-free Medium for Cells Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Serum-free Medium for Cells Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Serum-free Medium for Cells Sales by Type (2021-2032)
- 6.1.1 Global Serum-free Medium for Cells Sales by Type (2021-2032) & (ml)
- 6.1.2 Global Serum-free Medium for Cells Sales Market Share by Type (2021-2032)
- 6.2 Global Serum-free Medium for Cells Revenue by Type (2021-2032)
- 6.2.1 Global Serum-free Medium for Cells Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Serum-free Medium for Cells Revenue Market Share by Type (2021-2032)
- 6.3 Global Serum-free Medium for Cells Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Serum-free Medium for Cells Sales by Application (2021-2032)
- 7.1.1 Global Serum-free Medium for Cells Sales by Application (2021-2032) & (ml)
- 7.1.2 Global Serum-free Medium for Cells Sales Market Share by Application (2021-2032)
- 7.2 Global Serum-free Medium for Cells Revenue by Application (2021-2032)
- 7.2.1 Global Serum-free Medium for Cells Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Serum-free Medium for Cells Revenue Market Share by Application (2021-2032)
- 7.3 Global Serum-free Medium for Cells Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Serum-free Medium for Cells Value Chain Analysis
- 8.1.1 Serum-free Medium for Cells Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Serum-free Medium for Cells Production Mode & Process
- 8.2 Serum-free Medium for Cells Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Serum-free Medium for Cells Distributors
- 8.2.3 Serum-free Medium for Cells Customers
9 Global Serum-free Medium for Cells Analyzing Market Dynamics
- 9.1 Serum-free Medium for Cells Industry Trends
- 9.2 Serum-free Medium for Cells Industry Drivers
- 9.3 Serum-free Medium for Cells Industry Opportunities and Challenges
- 9.4 Serum-free Medium for Cells Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst